| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 732336 | [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide | 0.00433056621075589 | -0.21945006 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.00433056621075589 | 0.175087 |
| NSC 756169 | GSK317314A | 0.00433056621075589 | -0.042900476 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.00567322425730621 | -0.18953387 |
| NSC 244404 | Null | 0.00567322425730621 | -0.4149517 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.00567322425730621 | -0.22509184 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.00567322425730621 | -0.21669775 |
| NSC 354974 | Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- | 0.00567322425730621 | 0.1745078 |
| NSC 363813 | Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- | 0.00567322425730621 | -0.047279552 |
| NSC 683694 | Null | 0.00567322425730621 | -0.20892592 |